Consistent with the critical regulatory role of PIN1 in cancer development, it has been reported that aberrant expression of PIN1 is associated with cancers, such as breast cancer [7], [11] and prostate cancer [12]. This evidence concerns the gene PIN1 and prostate carcinoma.